HB 2882 – Illinois

Status: Inactive / Dead
Year Introduced: 2019
Link: http://www.ilga.gov/legislation/BillStatus.asp?DocNum=2882&GAID=15&DocTypeID=HB&SessionID=108&GA=101

GENERIC DRUG PRICING. Creates the Pharmaceutical and Health Affordability: Restrictions on Manufacturers’ Amoral Behavior Through Reasonable Oversight Act. Provides that a manufacturer or wholesale drug distributor shall not engage in price gouging in the sale of an essential off-patent or generic drug. Provides that the Director of Healthcare and Family Services or Director of Central Management Services may notify the Attorney General of any increase in the price of any essential off-patent or generic drug under the Medical Assistance Program under the Illinois Public Aid Code or a State health plan, respectively, that amounts to price gouging.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found